Immune clues to psychosis treatment: 500-Person study launches

NCT ID NCT06687694

First seen Mar 27, 2026 · Last updated May 15, 2026 · Updated 6 times

Summary

This study looks at how the immune system might influence psychotic symptoms and how well antipsychotic medications work. Researchers will collect blood and spinal fluid from 500 people with psychosis who are starting or changing medication, plus a healthy comparison group. The goal is to find biological markers that could help diagnose psychosis, choose the best treatment, and track progress. Findings may lead to future immune-based therapies for these conditions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • South London and Maudsley NHS Foundation Trust

    RECRUITING

    London, United Kingdom, SE5 8AB, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.